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Comparison of Percutaneous Nephrolithotomy Using Pneumatic 
Lithotripsy (Lithoclast
Ⓡ) Alone or in Combination with Ultrasonic 
Lithotripsy
C one Cho, Ji Hyeong Yu, Luck Hee Sung, Jae Yong Chung, Choong Hee Noh
Department of Urology, Inje University College of Medicine, Seoul, Korea
Purpose: Percutaneous nephrolithotomy (PCNL) is the procedure of choice for treating 
large renal stones. Pneumatic lithotripsy (Lithoclast
Ⓡ) is effective regardless of the 
stones’ composition, and ultrasonic lithotripsy allows the aspiration of small debris dur-
ing lithotripsy. We investigated the efficacy and safety of PCNL via Lithoclast
Ⓡ alone 
or combined with ultrasonic lithotripsy.
Materials and Methods: Thirty-five (group A) and 39 (group B) patients underwent 
Lithoclast
Ⓡ PCNL and combination therapy, respectively, from May 2001 to March 
2010, and the two groups were compared in terms of stone size, location, and composi-
tion; operative time; average number of treatments; hospital days; hemoglobin loss; 
ancillary procedures; rate of device failure; and initial and total stone-free rates.
Results: The two groups did not differ significantly in preoperative stone size, location, 
or composition; the average number of treatments; or the initial and overall stone-free 
rates. However, combination therapy was associated with a significantly lower oper-
ative time (181±50 vs. 221±65 min, respectively, p=0.004), number of hospital days 
(11.6±3.8 vs. 14.2±4.4 days, respectively, p=0.009), and average hemoglobin loss 
(1.12±0.61 vs. 1.39±1.02 g/dl, respectively, p=0.013). Transfusions were required in 6 
patients (4 and 2 in each group, respectively), but there were no significant complica-
tions related to percutaneous access. There were 2 (5.7%) mechanical failures 
(Lithoclast
Ⓡ probe fracture) in the group A and 5 (12.8%) in the group B (2 cases of suc-
tion tube obstruction, 3 cases of overheating). 
Conclusions: The combination of ultrasonic lithotripter and Lithoclast
Ⓡ is more effec-
tive than Lithoclast
Ⓡ alone because it significantly decreases operative time, hemoglo-
bin loss, and the hospital stay. This may reflect the superior power of Lithoclast
Ⓡ and 
the ability to aspirate the debris during ultrasonic lithotripsy.
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INTRODUCTION
Fernstrom and Johansson first removed a renal calculus 
through a nephrostomy tract in 1976, and percutaneous 
nephrolithotomy (PCNL) is now accepted as the procedure 
of choice for those patients who have large renal stones (＞2 
cm in diameter), infected stones, or lower calyceal stones 
with obstruction or anatomical variations in the renal col-
lecting system as well as for those patients in whom prior 
extracorporeal shock wave lithotripsy (ESWL) has failed 
[1]. ESWL of larger stone masses results in many stone 
fragments that rarely pass down the ureter spontaneously 
without causing an obstruction.
    In recent decades, endoscopic technology and operative 
techniques have consistently advanced, which has in-
creased the success rate (＞90%) of PCNL and decreased Korean J Urol 2010;51:783-787
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TABLE 1. Patients’ characteristics
Ultrasonic  
Lithoclast
Ⓡ lithotriptor p-value
＋Lithoclast
Ⓡ
No. of patients 35 39
Mean age (yr) 55.9±14.5 54.5±13.3 0.660
Male:female 19:16 23:16
Mean stone size 29.0±17.6 33.3±18.4 0.318
Type of stone 0.510
a
   Complete staghorn stone   6   8
   Partial staghorn stone 14 16
   Pelvis stone    8 10
   Calyceal stone    7   5
a: chi-square comparison with linear by linear
the associated complications and morbidity [2]. Conse-
quently, a wide range of lithotripsy techniques are cur-
rently available. One of these is ultrasonic lithotripsy, in 
which the stones are fragmented while suction is applied 
simultaneously [3]. This technique induces minimal tissue 
injury and could be considered as a standard modality for 
PCNL. However, the fragmentation process can be labori-
ous, especially if the stone is large or dense, and continuous 
irrigation is needed to prevent the probe from overheating. 
Pneumatic lithotripsy may be more suitable for harder 
stones because it is more powerful than the other litho-
tripsy techniques and it can minimize tissue injury when 
applied cautiously. However, a disadvantage of this techni-
que is that the stone fragments must be extracted with 
graspers, which is highly time-consuming.
    Little has been published about the use of ultrasonic lith-
otripters for PCNL in Korea. The objective of this study was 
therefore to compare the effectiveness of pneumatic litho-
tripsy combined with ultrasonic lithotripsy with the effec-
tiveness of pneumatic lithotripsy alone.
MATERIALS AND METHODS
A review of medical records between May 2001 and March 
2010 identified 74 patients who had undergone PCNL by 
the same experienced surgeon. Details of the patients and 
the procedures and the postoperative clinical results and 
complications were recorded. Of the 74 patients, 35 (group 
A) underwent PCNL with Lithoclast
Ⓡ (Richard Wolf 
GmbH, Knittlingen, Germany), and 39 (group B) under-
went simultaneous combination therapy with Lithoclast
Ⓡ 
and an ultrasonic lithotripter (Richard Wolf GmbH, 
Knittlingen, Germany). The patients were randomly as-
signed to receive PCNL performed by pneumatic litho-
tripsy or a combination of ultrasonic and pneumatic 
lithotripsy. Because the ultrasonic device was set up in our 
hospital in 2006, a few group A patients underwent PCNL 
with the Lithoclast
Ⓡ only since 2006. There were no sig-
nificant differences between the two groups in terms of the 
mean patient age (55.9±14.5 vs. 54.5±13.3 years, re-
spectively, p=0.660) (Table 1). The inclusion criteria in-
cluded the presence of large (＞2 cm) renal stones, low-pole 
stones, and partial and complete staghorn calculi. The ex-
clusion criteria were a patient age below 18 years, the pres-
ence of a coagulopathy, and pregnancy.
    The stone size and type were documented preopera-
tively. Before the operation, all the patients were subjected 
to intravenous urography (IVU) or computed tomography 
(CT), and if needed, an assessment of renal function was 
done by dimercaptosuccinic acid scanning. The urine cul-
ture had to be sterile and antibiotics were given 12 hours 
before the operation.
    For the group A patients, lithotripsy was performed by 
using a Lithoclast
Ⓡ, and lithotripsy was continued until 
the stone had fragmented into pieces small enough to be 
removed directly by a two- or three-pronged grasper. For 
the group B patients, lithotripsy was usually first initiated 
with a few bursts of the Lithoclast
Ⓡ, after which the ultra-
sonic lithotripter was used. At the end of the operation, a 
nephrostomy tube (a 20 Fr self-retaining balloon catheter) 
was placed and maintained until the hematuria dis-
appeared.
    A number of parameters were recorded. The success of 
PCNL treatment was evaluated by two categories: 1) the 
initial stone-free rate, which was defined as no visible re-
sidual calcification or remnant calcification smaller than 
4 mm in diameter (clinically insignificant residual frag-
ment) on a plain KUB or CT image after the first session, 
and 2) the overall stone-free rate, which was defined as no 
residual fragment or ＜4 mm on the KUB film or CT image 
4 weeks after the last treatment. The number of sessions 
referred to the number of PCNL procedures each patient 
underwent. The total operation time was calculated by 
adding the time taken to perform the percutaneous neph-
rostomy to the time taken for the lithotripsy. Hospital days 
referred to the total number of days the patients stayed in 
the hospital after the first PCNL, during which time some 
patients also underwent a second or third PCNL procedure. 
After the last PCNL procedure, ESWL was used as an ac-
cessory treatment in the patients with residual stones ≥4 
mm. The characteristics of the stones were evaluated. The 
complications associated with the PCNL session were re-
corded, including postoperative fever, total hemoglobin 
loss, need for transfusion, perforation of the renal pelvis, 
and the development of pneumothorax or pleural effusion. 
The total rates of technical lithotripter-related problems 
that occurred during the PCNL were also recorded.
    All data were statistically analyzed by using MedCalc
Ⓡ 
(MedCalc Software, Mariakerke, Belgium). The results 
were expressed as Means±SDs. Student’s t-test was used 
to compare the mean values of the continuous variables, 
whereas the chi-square test was used to compare the dis-
crete variables. A p-value less than 0.05 was considered 
significant. Korean J Urol 2010;51:783-787
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TABLE 2. Treatment outcomes after PCNL
Ultrasonic  
Lithoclast
Ⓡ lithotriptor p-value
＋Lithoclast
Ⓡ
Success rate (%)
   Initial stone free rate 45.7 61.5 0.177
   Overall stone free rate 85.7 92.3 0.369
No. of sessions   1.71±0.93   1.44±0.64 0.134
Operative time (min) 221±65    181±50.0 0.004
Hospital days 14.2±4.4 11.6±3.8 0.009
No. of patients with  5 3
 residual fragment
Stone composition (%) 0.935
a
   Calcium oxalate 19 (54.2) 20 (51.2)
   Calcium phosphate   5 (13.9)   6 (15.3)
   Struvite   6 (17.1)   9 (23.0)
   Uric acid 3 (8.5) 3 (7.6)
   Cysteine 2 (5.7) 1 (2.5)
PCNL: percutaneous nephrolithotomy, 
a: chi-square comparison
with linear by linear
TABLE 3. Complications of percutaneous nephrolithotomy
Ultrasonic  
Lithoclast
Ⓡ lithotriptor p-value
＋Lithoclast
Ⓡ
Postoperative fever  0 0
  (≥38.5
oC)
Hb loss 1.39±1.02 1.12±0.61 0.013
Transfusion 4 2
Perforation of renal pelvis 0 0
Pneumothorax or pleural 0 0
  effusion
Total technical problems
   Lithoclast probe fracturing 2 0
   No. of suction tubing n/a 3
    obstructions
   No. of lithotrite n/a 2
    malfunctions
n/a: not applicable
RESULTS
As shown in Table 1, groups A (Lithoclast
Ⓡ alone) and B 
(Lithoclast
Ⓡ in combination with ultrasonic lithotripsy) 
were similar in terms of stone size (29.0±17.6 and 
33.3±18.4 mm, respectively, p=0.318). The two groups also 
did not differ significantly in the distribution of stone type 
(p=0.510): 20 group A patients and 24 group B patients had 
staghorn calculi, and the remaining stones were renal ca-
lyx stones or renal pelvis stones.
    After the first PCNL session, 19 (54.3%) of the group A 
patients and 15 (38.5%) of the group B patients continued 
to have clinically significant residual stone fragments, and 
they had to undergo a second or a third PCNL. Thus, as 
shown in Table 2, the initial stone-free rates for groups A 
and B were 45.7% and 61.5%, respectively (p=0.177). The 
average number of treatment sessions for groups A and B 
was 1.71±0.93 and 1.44±0.64, respectively; this difference 
did not achieve statistical significance (p=0.134). Whereas 
groups A and B did not differ significantly in their overall 
stone-free rates or stone composition (p=0.369, p=0.935), 
combination therapy significantly reduced the total oper-
ative time (181±50 vs. 221±65 min, respectively, p=0.004) 
and the duration of the postoperative hospital stay 
(11.6±3.8 vs. 14.2±4.4, respectively, p=0.009). After the 
last PCNL session, 5 group A patients (14.3%) and 3 group 
B patients (7.7%) continued to have clinically significant 
residual stone fragments and therefore underwent ESWL 
treatment.
    The rates of various complications associated with the 
first PCNL are shown in Table 3. Combination therapy sig-
nificantly reduced the postoperative hemoglobin loss 
(1.12±0.61 vs. 1.39±1.02 g/dl, respectively, p=0.013). Four 
(11.4%) and 2 (6.9%) group A and B patients, respectively, 
experienced bleeding that required a transfusion to man-
age it. None of the patients experienced severe bleeding 
that required embolization. There were also no cases of 
pleural or lung injury due to the puncture. None of the pa-
tients required ureteral catheterization or ureteroscopy to 
remove residual stones. Lithoclast
Ⓡ alone was associated 
with mechanical failures in 2 group A patients (5.7%), and 
this was due to fracturing of the lithoclast probe (Table 3). 
Combination therapy was associated with mechanical 
malfunction in 5 group B patients (12.8%) due to suction 
tube obstruction (2 patients) and device failure that re-
quired resetting of the machine every 30 minutes (3 pa-
tients).
DISCUSSION
Although ESWL has revolutionized the management of 
urinary stones, PCNL still plays an important role in the 
treatment of large or multiple kidney stones [4]. The PCNL 
procedure can be divided into three steps, namely, percuta-
neous access, tract dilation, and stone fragmentation. The 
success of PCNL is related to the ability to achieve an opti-
mal access tract. A subcostal tract through the posterior 
middle or the inferior calyx may be acceptable for stones 
in the renal pelvis and those in the middle or inferior calyx 
[5]. For stones in the superior calyx and for staghorn stones, 
an approach through the superior calyx has clear advan-
tages with acceptable complications. A significant chest 
complication rate of about 5% must be considered when 
choosing the supracostal approach [5]. In the present 
study, the punctures were made at the mid or lower calyx 
to prevent chest complications. Indeed, no complications 
related to the puncture were observed. Another funda-
mental PCNL procedural step is the dilation of the tract 
that creates the nephrostomy access. This is commonly 
achieved by using Amplatz fascial dilators, Alken metal di-
lators, or pneumatic balloon dilators [6]. Park et al have re-
ported on the advantage of the attending radiologist pre-Korean J Urol 2010;51:783-787
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operatively achieving an access tract, which reduces oper-
ation time and complications [7].
    With regard to the third PCNL procedural step, namely, 
stone fragmentation, a number of lithotripsy approaches 
have been developed. The first is electrohydraulic litho-
tripsy (EHL), which is based on spark-gap technology and 
was first introduced by Yutkin (1955). Raney and Handler 
have reported the use of EHL for open nephrolithotomy [8]. 
EHL is cheaper than the other lithotripsy devices. However, 
despite the technical improvements and extensive clinical 
experience with EHL, it remains the least safe of all litho-
tripsy devices. In fact, Hofbauer et al showed that EHL is 
associated with a higher rate of perforation than is the use 
of a pneumatic lithotripter (17.6% vs. 2.6%, respectively) 
[9].
　Another lithotripter is the holmium:yttrium-aluminum- 
garnet (Ho:YAG) laser, which is a high-energy pulse sol-
id-state laser. The efficacy of the Ho:YAG laser is correlated 
with the pulse energy output. It has been reported to be a 
safe and effective treatment modality for large renal 
stones, even at high power settings [10,11]. The advantages 
of the Ho:YAG laser are that it effectively fragments all 
sorts of renal calculi, and the fibers are small enough to be 
passed through flexible endoscopes [12]. However, one dis-
advantage of the Ho-YAG laser is that the resulting stone 
fragments must be extracted by grasping each one 
individually. Another disadvantage is that the inadvertent 
exposure of the urothelium to the laser beam may lead to 
perforation or bleeding from shock-wave exposure and 
heating. Moreover, the cost of this laser system is high [13].
    The Lithoclast
Ⓡ lithotripter uses pneumatic ballast, 
which crushes the stone without producing any thermal ef-
fects [14]. Because this mechanical energy passes along the 
metal wire to the stone, the probe works like a chisel on the 
stone surface [15]. This modality destroys all stones, re-
gardless of their composition. Another advantage of the 
Lithoclast
Ⓡ is that its cost is low [16]. However, it also suf-
fers from the disadvantage that the stone fragments it pro-
duces are usually large and are likely to be displaced. In 
addition, in the case of granulation tissue-wrapped stones 
or impacted stones in a narrowed calyceal neck, hemor-
rhage is likely because of the mechanical impact from the 
rod and repeated friction between the stone and the mucosa 
of the renal collection system, and this hemorrhage blurs 
the vision of the field.
    Ultrasonic lithotripsy uses mechanical energy that is 
created by piezo-ceramic elements. The vibrations (23-27 
Hz) are transmitted through rigid probes, which results in 
a drilling action [17,18]. This lithotripter allows stone frag-
ments to be simultaneously aspirated through the hollow 
probe, which helps to remove the stone particles. In partic-
ular, soft matrix stones such as phosphate-containing cal-
culi can be readily suctioned out. Ultrasonic lithotripsy is 
very safe, because activating the probe when it is in contact 
with the urothelium results in only superficial erosion. 
However, ultrasound lithotripsy is somewhat less effective 
for very hard renal stones or for hard stones with a smooth 
surface [19]. In such cases, the lithotripter sometimes only 
succeeds in drilling deep holes into the stone without induc-
ing any fragmentation. In addition, continuous irrigation 
is needed to prevent the probe from overheating. Notably, 
to prevent failure of an overheated device, the ultrasonic 
lithotripter must be started at a power mode between 1 and 
2 (as recommended by the manufacturer), after which the 
power can be increased as needed up to 3 [20].
    The ultrasound and pneumatic lithotripsy technologies 
have recently been combined to produce a single device. 
Compared with an ultrasonic device, the combined pneu-
matic and ultrasonic device is associated with significantly 
increased lithotripsy efficacy (stone disintegration) and ef-
ficiency (stone fragmentation and clearance) [21,22]. The 
main advantage of using an ultrasonic lithotripter in com-
bination with a pneumatic lithotripter is that the frag-
mented stones can be cleared by active negative pressure 
suction. No other instruments are needed for the whole- 
stone fragmenting and clearing process. Thus, there is no 
need to wash the nephroscope, which requires that it be re-
peatedly withdrawn from and then reinserted into the 
body. This reduces the intra- and postoperative complica-
tion rates, increases the stone-free rate, and shortens the 
operation time. Because negative pressure suction main-
tains the renal collection system at a low pressure, this also 
reduces the risk of bacterial infection. When considering 
the stone fragmentation efficacy of combined Lithoclast
Ⓡ 
and ultrasonic lithotripsy, Lithoclast
Ⓡ is more powerful for 
treating hard stones, whereas small fragments, gran-
ulation tissue-wrapped stones, impacted stones, and 
stones with a soft matrix (e.g., phosphate-containing calcu-
li) are particularly suitable for aspiration through the ul-
trasound probe. Stone fragments can either be cleared out 
by forceps after crude fragmentation with the Lithoclast
Ⓡ 
or be flushed out through the hollow probe of the ultrasound 
lithotripter. In our study, the combination technique had 
a valuable synergistic effect. 
    In an actual clinical setting, the the combined use of 
these two instruments can maximize their advantages and 
minimize their disadvantages. Even in cases in which hard 
stones are present, for which fragmentation is difficult 
while bubbles are formed despite the use of ultrasonic litho-
tripsy, the surgical procedure can be performed both easily 
and safely. The stones can be fragmented to the appro-
priate size by using the power that a pneumatic lithotripter 
generates to a sufficient extent and the superior displace-
ment of a stone or the occurrence of hemorrhagic events can 
be prevented by using the active negative suction of ultra-
sonic lithotripsy. Even in cases in which soft matrix stones 
are present and where the removal of stones is somewhat 
troublesome with a pneumatic lithotripter, the surgical 
procedure can be performed both easily and safely by using 
the active negative suction of ultrasonic lithotripsy. 
Compared with a single use of ultrasonic lithotripsy, any 
device malfunction (probe fracture, suction tubing ob-
struction) occurred at a lower frequency. Besides, even in 
cases in which hemorrhage occurred as a result of percuta-Korean J Urol 2010;51:783-787
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neous access or tract dilation, an access could easily be 
made for the surgical field with use of the suction device 
with no necessity for removing the stones one by one with 
forceps .
    The present study was limited by the fact that it was a 
retrospective, single-center study with a relatively small 
sample size (74 patients). In addition, the stones were not 
divided according to their composition into hard and soft 
stones. Although a device that combines ultrasonic litho-
tripsy with Lithoclast
Ⓡ has recently been invented, little 
was known in Korea about the benefits of combining these 
two lithotripsy technologies, which makes this study use-
ful for actual Korean medical practice.
CONCLUSIONS
Disintegration of renal stones by use of pneumatic litho-
tripsy (Lithoclast
Ⓡ) alone or together with ultrasonic litho-
tripsy was found to be effective. The combination was asso-
ciated with significant reductions in the operation time, he-
moglobin loss, and hospital stay as compared with the use 
of Lithoclast
Ⓡ alone, and this was true regardless of the 
stones’ composition. Thus, combining a pneumatic litho-
tripter with an ultrasonic lithotripter, which permits using 
the superior power of the Lithoclast
Ⓡ and enables the aspi-
ration of debris during ultrasonic lithotripsy, is highly ad-
vantageous for treating renal calculi. 
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